OncoImmunity develops machine-learning methods for personalized cancer medicine. Our flagship product predicts a patient response to cancer immunotherapy, from genomic data. We are a growing team of developers from 7 different countries, including Norway, consisting of a diverse mix of data-scientists, bioinformaticians and software engineers. We work in a collaborative, innovative and fun environment, committed to deliver powerful machine-learning solutions in the field of cancer immunotherapy.